Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Premix signs $79.9 million contract for a new production facility in the U.S.

The major agreement will help secure critical diagnostic supplies in the United States and better serve Premix’s global customers.     Gastonia / Helsinki, May 9, 2022 – The U.S. Department of Defense, working with the Department of Health and Human Services, awarded a $79.9 million contract to Premix, Inc. to establish a plastic compound manufacturing plant in North Carolina. The facility will primarily produce plastic materials for diagnostic testing. The facility will be built in Gaston County, centrally located in the growing region of advanced manufacturing in the southeast U.

Hexagon Purus Maritime receives inaugural order for hydrogen cylinders for maritime applications

Hexagon Purus Maritime, a wholly owned subsidiary of Hexagon Purus, has received its inaugural order for cylinders to be used in onboard storage of hydrogen in maritime vessels. Hexagon Purus’ type 4 hydrogen cylinders will be used in onboard swappable storage containers for maritime vessels operating in the inland waterways in Europe. The value of the order is approximately EUR 1.1 million (approx. NOK 11 million). Driving Energy Transformation “Our Type 4 high-pressure cylinders are at the core of what we do and with their corrosion resistance and long lifetime, the cylinders enable

Alligator Bioscience expands its Board of Directors with the appointment of Staffan Encrantz and Denise Goode

Lund, Sweden, May 9, 2022 - Alligator Bioscience (Nasdaq Stockholm: ATORX) today announces the appointment of Staffan Encrantz and Denise Goode as members of the company's Board of Directors. Mr. Encrantz is the founder and Chairman of Allegro Investment Fund, a $750 million fund which has been investing in companies across a number of industries for 30 years and is also a major shareholder in Alligator Bioscience. Ms. Goode has more than 25 years of experience in business leadership and innovation, having held a number of senior executive and board-level positions in the pharmaceutical and

ChemoTech supports a Ukrainian hospital by selling an IQwave™ at a discounted price

After ChemoTech recently received a direct request for help from Ulis Hospital in Ukraine, the Company of course agreed to sell an IQwave™ to the hospital at a heavily discounted price.The registration of ChemoTech's TSE system, also known as IQwave 3.0 CE, began in autumn 2021 in Ukraine. This process was completed just before Russia's invasion of the country began.   During the spring, the Company had ongoing contact with the distributor, who already had a complete launch strategy that had to be suspended due to the current war. Ulis Hospital played a central role in the distributor'

GET Group AB (publ) resolves upon an issue of units to professional investors

The board of directors in GET Group AB (publ) (‘GET Group’ or the ‘Company’) has today resolved, pursuant to the authorisation by the annual general meeting held on 30 June 2021, on an issue of 18,000,000 shares and 18,000,000 warrants to professional investors. The new shares and warrants shall be issued as a unit where one unit consists of one share and one warrant of series 2022:1. The subscription price for all units is in total SEK 927,829.50.The board of directors in GET Group has today resolved, pursuant to the authorisation by the annual general meeting held on 30 June 2021, on a

Pagero Group AB (publ) (“Pagero”) to make a recommended cash offer to acquire Tungsten Corporation plc (“Tungsten”)

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY RESTRICTED JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION. THIS PUBLICATION IS NEITHER AN OFFER TO BUY OR SELL NOR AN INVITATION TO TENDER OR OFFER TO BUY OR SELL SHARES.The boards of directors of Tungsten and Pagero are pleased to announce that they have agreed the terms of a recommended all cash offer to be made by Pagero to acquire the entire issued and to be issued ordinary share capital of Tungsten at a price of

Optomed Oyj - Managers' Transactions

Optomed Plc - Managers' Transactions – 9 May 2022, at 12.00 EET Optomed Oyj - Managers' Transactions ____________________________________________   Person subject to the notification requirement Name: Tauriainen, Reijo Position: Member of the Board/Deputy member Issuer: Optomed Oyj LEI: 7437009IVYWGEE4S7B77   Notification type: INITIAL NOTIFICATION Reference number: 7437009IVYWGEE4S7B77_20220509091406_5 ____________________________________________   Transaction date: 2022-05-06 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHARE ISIN:

Optomed Oyj - Managers' Transactions

Optomed Plc - Managers' Transactions – 9 May 2022, at 12.00 EET Optomed Oyj - Managers' Transactions ____________________________________________   Person subject to the notification requirement Name: Kopsala, Seppo Position: Chief Executive Officer Issuer: Optomed Oyj LEI: 7437009IVYWGEE4S7B77   Notification type: INITIAL NOTIFICATION Reference number: 7437009IVYWGEE4S7B77_20220509091134_4 ____________________________________________   Transaction date: 2022-05-06 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHARE ISIN: FI4000410881

Optomed Oyj - Managers' Transactions

Optomed Plc - Managers' Transactions – 9 May 2022, at 12.00 EET Optomed Oyj - Managers' Transactions ____________________________________________   Person subject to the notification requirement Name: Mäkinen, Seppo Position: Member of the Board/Deputy member Issuer: Optomed Oyj LEI: 7437009IVYWGEE4S7B77   Notification type: INITIAL NOTIFICATION Reference number: 7437009IVYWGEE4S7B77_20220509091542_6 ____________________________________________   Transaction date: 2022-05-06 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHARE ISIN:

Cline presents at Aktiedagen Göteborg 16[th] May at 3pm

Cline Scientific AB (“Cline” or “The Company”) is participating in Aktiespararna’s Aktiedagen Göteborg at Svenska Mässan on Monday the 16th May 15:00 (in Swedish). CEO Patrik Sundh and VP of R&D Dr. Hanne Evenbratt will present Cline and answer your questions.Participants can also watch the live broadcast at www.aktiespararna.se/tv/live. The event is open to everyone and does not require any membership in Aktiespararna. No registration is required to follow the event digitally.   Participants can ask questions to the presenters by sending an SMS to 079-347 98 45 or emailing event@

Optomed Oyj - Managers' Transactions

Optomed Plc - Managers' Transactions – 9 May 2022, at 12.00 EET Optomed Oyj - Managers' Transactions ____________________________________________   Person subject to the notification requirement Name: Salonen, Petri Position: Member of the Board/Deputy member Issuer: Optomed Oyj LEI: 7437009IVYWGEE4S7B77   Notification type: INITIAL NOTIFICATION Reference number: 7437009IVYWGEE4S7B77_20220509091233_4 ____________________________________________   Transaction date: 2022-05-06 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHARE ISIN:

Tietoevry’s commitments to Science Based Targets verified

Tietoevry ’s carbon reduction targets have been verified by the Science Based Targets initiative  (SBTi) as being in line with the level of reduction needed to limit global warming to 1.5°C. This is an important milestone towards Tietoevry’s ambition of becoming net zero in own operations by 2025.To highlight the importance of sustainability across its operations, the company has included ESG indicators, CO\2\ reductions and diversity and inclusion, as part of its incentive program for the management. ”We take it upon ourselves to reduce our own carbon

REPORT ON MANAGERS’ TRANSACTIONS IN DAMPSKIBSSELSKABET NORDEN A/S

ANNOUNCEMENT NO. 113 - 9 MAY 2022 Under Article 19 of the Market Abuse Regulation Dampskibsselskabet NORDEN A/S is required to report transactions in Dampskibsselskabet NORDEN A/S’ shares by persons discharging managerial responsibilities and their close relatives. Name: Jan RindboReason: Reporting duty, CEOIssuer: Dampskibsselskabet NORDEN A/SISIN code: DK0010269844Instrument: SharesTransaction: Exercise of share optionsTrading date: 5 May

Flagging notification in accordance with Chapter 9 Section 10 of the Finnish Securities Markets Act

Basware Corporation, stock exchange release, 09 May 2022 at 11:30 a.m. EESTBasware Corporation has received on 6 May 2022 the following notification pursuant to Chapter 9, Section 5 of the Finnish Securities Market Act from The Goldman Sachs Group, Inc. according to which their total holding of shares of Basware Corporation has increased above five (5) percent on 5 May 2022. According to the notification, the reason for the notification was an acquisition or disposal of shares or voting rights and acquisition or disposal of financial instruments. Basware Corporation has one series of

SAGA: Notice to the Ordinary General Meeting

The Ordinary General Meeting in Saga Pure ASA will take place on 30 May 2022 at 10.00hrs (CET) as an electronic meeting. Information about participation and registration appears from the notice and its appendices and will be available on the Company's website www.sagapure.com. Further information about the electronic participation is enclosed to this message and will be published on the Company's website www.sagapure.com.  Shareholders may submit their votes electronically in advance. Please see the instructions in the enclosed Notice. For further information, please contact:

Magnus Hansson steps down as CFO of Lime Technologies

Lime Technologies AB (publ)'s Chief Financial Officer (CFO) Magnus Hansson has today announced that he is terminating his employment. Recruitment of a replacer will begin immediately. To ensure an orderly transition, Magnus will continue in his current role until a new CFO is in place. Magnus Hansson has been CFO since 2015 and has, among other things, been part of taking Lime to the stock market in 2018."Magnus has played a key role at Lime, not least during the listing process. I have had the privilege of working with Magnus for many years. He has always been a true team player and a

Veidekke: To build new drainage tunnel for Stockholm Vatten och Avfall AB

Veidekke has signed a contract with Stockholm Vatten och Avfall AB for the construction of the new Östberga tunnel, which is part of Stockholm's future wastewater treatment system. The execution contract has a value of approx. SEK 600 million. The new tunnel is expected to be commissioned in 2026.The new Östberga tunnel is an environmental improvement project intended to make Stockholm's wastewater structure more robust and able to handle larger volumes of wastewater and precipitation. The project comprises two main parts. First, Veidekke will construct a 2.2 kilometres mountain tunnel

SimCorp A/S – Share buyback program

Company Announcement no. 20/2022On February 15, 2022 SimCorp A/S announced a share buyback program in compliance with the provisions of Regulation No. 596/2014 of the European Parliament and of the Council on market abuse (the Market Abuse Regulation - MAR) and delegated legislation under MAR. In connection with the program SimCorp A/S will repurchase shares for an amount of up to EUR 20.0m, to be executed during the period from February 15, 2022 to July 31, 2022. The following transactions have been executed under the program:          Date                 Number of shares

RaySearch collaborates with GE Healthcare to improve radiation oncology treatment planning

RaySearch Laboratories AB (publ) is proud to announce an agreement to collaborate with GE Healthcare, a leading global medical technology, diagnostics, and digital solutions company, to develop a new radiation therapy simulation and treatment planning workflow solution, designed to make use of the latest advancements in treatment planning technology.The companies aim to combine RaySearch’s advanced treatment planning system RayStation®* with GE Healthcare’s leading multi-modality (CT/MR/molecular imaging) simulator systems to make cancer treatment faster and more precise.  More than 60

Plane and bus companies across Europe urged to allow pet-friendly passage for Ukrainian refugees

Humane Society International/Europe warns of pets being abandoned because some travel companies refuse their transportBRUSSELS (May 9, 2022) — Travel companies are urged by Humane Society International/Europe to provide safe, pet-friendly passage for Ukrainian refugees travelling with their animals, to avoid cats, dogs and others being abandoned at bus or airplane terminals due to being refused travel. The animal protection charity’s teams in Poland and Romania were alerted that refugees attempting to travel further into the EU are faced with the impossible decision to leave their pets

poLight ASA - Invitation to presentation of Q1 2022 results

poLight ASA will release its first quarter 2022 results on Thursday 12 May 2022 at 7.00 am CEST. The quarterly report and presentation will be made available on the company's website www.polight.com  and www.newsweb.no. CEO Øyvind Isaksen and CFO Alf Henning Bekkevik will present the company's results at 09:00 am CEST through live webcast. Please join the Q1 2022 results webcast by clicking here: https://channel.royalcast.com/landingpage/hegnarmedia/20220512_6/ 

Ingka Group to accelerate expansion by investing EUR 3 billion by end of next year

Ingka Group, the largest IKEA retailer, will accelerate expansion by investing more than EUR 3 billion in new and existing stores by the end of next year to become more accessible for customers – whenever and wherever they want to interact with IKEA.Life at home has never been more important and the new investment reflects the ongoing retail transformation and the company’s unchanged determination to get closer to where customers are, while navigating global disruptions caused by the war in Ukraine and the pandemic. As online shopping continues to increase rapidly, physical IKEA stores

Read original

Viaplay adds ‘R.S.V.P.’ to Swedish original film slate

· Lisa Carlehed (‘The Emigrants’) stars in Swedish romantic comedy film   · ‘R.S.V.P.’ is Viaplay’s latest feature-length Nordic production · Viaplay set to premiere at least 70 Originals in 2022 The Swedish romantic comedy ‘R.S.V.P.’ will be the next original film in Viaplay’s ongoing investment in feature-length Nordic storytelling. Set to premiere in the fourth quarter of 2022, ‘R.S.V.P.’ brings together some of Sweden’s hottest talents in front of and behind the camera, with the lead role played by Lisa Carlehed, recently nominated for Best Actress at Sweden’s 2022 Guldbagge

Relais Group Plc will publish its Interim Management Statement from January-March 2022 on 12 May 2022 at 9:00 a.m. EET, webcast at 10:00 a.m.

Relais Group PlcPress Release, 9 May 2022 at 10:00 a.m. EET Relais Group Plc will publish its Interim Management Statement from January-March 2022 on Thursday, 12 May 2022 at 9:00 a.m. EET and it will be available after publishing on the company's website at https://relais.fi/en/investors/. Relais Group will arrange a webcast for analysts, investors and media on 12 May 2022, at 10:00 a.m. EET. The webcast will be held in English. Relais Group’s CEO Arni Ekholm and CFO Pekka Raatikainen will host the event. The webcast can be followed at https://relais.videosync.fi/interimreport-q1-

There are no items matching the current filter
There are no more items matching the current filter
Back to top